AAAAAA

   
Results: 1-22 |
Results: 22
EFFECTS OF SHORT-TERM PREOPERATIVE TAMOXIFEN ON STEROID-RECEPTOR AND KI-67 EXPRESSION IN PRIMARY BREAST-CANCER - AN IMMUNOCYTOCHEMICAL STUDY
Authors: BAJETTA E CELIO L DILEO A BARTOLI C PILOTTI S LEUTNER M BONO A FERRARI L BUZZONI R ZILEMBO N DECANDIS D MOGLIA D
Citation: E. Bajetta et al., EFFECTS OF SHORT-TERM PREOPERATIVE TAMOXIFEN ON STEROID-RECEPTOR AND KI-67 EXPRESSION IN PRIMARY BREAST-CANCER - AN IMMUNOCYTOCHEMICAL STUDY, International journal of oncology, 12(4), 1998, pp. 853-858
BONE METABOLISM MARKERS IN PREMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH THE LHRH ANALOG TRIPTORELIN ALONE OR IN COMBINATION WITH THE AROMATASE INHIBITOR FORMESTANE
Authors: MARTINETTI A CELIO L FERRARI L ZILEMBO N MARIANI L SEREGNI E BOMBARDIERI E GALANTE E STANI S BAJETTA E
Citation: A. Martinetti et al., BONE METABOLISM MARKERS IN PREMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH THE LHRH ANALOG TRIPTORELIN ALONE OR IN COMBINATION WITH THE AROMATASE INHIBITOR FORMESTANE, Annals of oncology, 9, 1998, pp. 87-87
THE COMBINATION OF AN LH-RH ANALOG AND AN AROMATASE INHIBITOR (AL) INPREMENOPAUSAL BREAST-CANCER - INFLUENCE ON THE INSULIN-LIKE-GROWTH-FACTOR (IGF) SYSTEM AND THE INTERLEUKIN (IL)-6
Authors: FERRARI L MARTINETTI A CELIO L BUZZONI R MARIANI L SEREGNI E BOMBARDIERI E POZZI P PROCOPIO G BAJETTA E
Citation: L. Ferrari et al., THE COMBINATION OF AN LH-RH ANALOG AND AN AROMATASE INHIBITOR (AL) INPREMENOPAUSAL BREAST-CANCER - INFLUENCE ON THE INSULIN-LIKE-GROWTH-FACTOR (IGF) SYSTEM AND THE INTERLEUKIN (IL)-6, Annals of oncology, 9, 1998, pp. 126-126
PRELIMINARY EXPERIENCE WITH HIGH-DOSE CISPLATIN, REDUCED GLUTATHIONE AND NATURAL INTERFERON-ALPHA IN DACARBAZINE-RESISTANT MALIGNANT-MELANOMA
Authors: BAJETTA E RIMASSA L CARNAGHI C DELVECCHIO M CELIO L CASSATA A
Citation: E. Bajetta et al., PRELIMINARY EXPERIENCE WITH HIGH-DOSE CISPLATIN, REDUCED GLUTATHIONE AND NATURAL INTERFERON-ALPHA IN DACARBAZINE-RESISTANT MALIGNANT-MELANOMA, Tumori, 84(1), 1998, pp. 48-51
EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER
Authors: FERRARI L BAJETTA E SEREGNI E MARTINETTI A ZILEMBO N NOBERASCO C BUZZONI R BOTTI C MASSARON S BICHISAO E CELIO L BOMBARDIERI E
Citation: L. Ferrari et al., EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER, International journal of oncology, 11(1), 1997, pp. 163-167
THE AROMATASE INHIBITOR LETROZOLE IN ADVANCED BREAST-CANCER - EFFECTSON SERUM-INSULIN LIKE GROWTH-FACTOR (IGF)-I AND IGF BINDING PROTEIN-3LEVELS
Authors: BAJETTA E FERRARI L CELIO L MARIANI L MICELI R DILEO A ZILEMBO N BUZZONI R SPAGNOLI I MARTINETTI A BICHISAO E SEREGNI E
Citation: E. Bajetta et al., THE AROMATASE INHIBITOR LETROZOLE IN ADVANCED BREAST-CANCER - EFFECTSON SERUM-INSULIN LIKE GROWTH-FACTOR (IGF)-I AND IGF BINDING PROTEIN-3LEVELS, Journal of steroid biochemistry and molecular biology, 63(4-6), 1997, pp. 261-267
THE LHRH ANALOG TRIPTORELINE (TRP) WITH OR WITHOUT THE AROMATASE INHIBITOR FORMESTANE (4-OHA) IN PREMENOPAUSAL ADVANCED BREAST-CANCER - A STUDY BY THE ITMO GROUP
Authors: CELIO L MARTINETTI A FERRARI L BUZZONI R BOMBARDIERI E ZILEMBO N MAIORINO L BAJETTA E
Citation: L. Celio et al., THE LHRH ANALOG TRIPTORELINE (TRP) WITH OR WITHOUT THE AROMATASE INHIBITOR FORMESTANE (4-OHA) IN PREMENOPAUSAL ADVANCED BREAST-CANCER - A STUDY BY THE ITMO GROUP, European journal of cancer, 33, 1997, pp. 691-691
PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH PRETREATED ADVANCED OVARIAN-CANCER - ACTIVITY IN PLATINUM-RESISTANT DISEASE
Authors: BAJETTA E DILEO A BIGANZOLI L MARIANI L CAPPUZZO F DIBARTOLOMEO M ZILEMBO N ARTALE S MAGNANI E CELIO L BUZZONI R CARNAGHI C
Citation: E. Bajetta et al., PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH PRETREATED ADVANCED OVARIAN-CANCER - ACTIVITY IN PLATINUM-RESISTANT DISEASE, Journal of clinical oncology, 14(9), 1996, pp. 2546-2551
NOVEL NONSTEROIDAL AROMATASE INHIBITORS - ARE THERE NEW PERSPECTIVES IN THE TREATMENT OF BREAST-CANCER
Authors: BAJETTA E CELIO L BUZZONI R BICHISAO E
Citation: E. Bajetta et al., NOVEL NONSTEROIDAL AROMATASE INHIBITORS - ARE THERE NEW PERSPECTIVES IN THE TREATMENT OF BREAST-CANCER, Tumori, 82(5), 1996, pp. 417-422
CLINICAL AND ENDOCRINE EFFECTS OF MEGESTROL-ACETATE IN WOMEN WITH PRETREATED ADVANCED BREAST-CANCER
Authors: VICARIO G CELIO L BAJETTA E ZAMPINO MG LONGHI A BUZZONI R BOTTI C BOGNI A BOMBARDIERI E RIMASSA L LAFFRANCHI A
Citation: G. Vicario et al., CLINICAL AND ENDOCRINE EFFECTS OF MEGESTROL-ACETATE IN WOMEN WITH PRETREATED ADVANCED BREAST-CANCER, Oncology Reports, 2(1), 1995, pp. 63-68
DOXIFLURIDINE IN PATIENTS WITH 5-FU RESISTANT COLORECTAL-CANCER
Authors: BAJETTA E DIBARTOLOMEO M SOMMA L VICARIO G CELIO L BIGNAMI P BANDIERI E BALDINI M
Citation: E. Bajetta et al., DOXIFLURIDINE IN PATIENTS WITH 5-FU RESISTANT COLORECTAL-CANCER, European journal of cancer, 31A, 1995, pp. 705-705
COMBINATION GOSERELIN AND TAMOXIFEN THERAPY IN PREMENOPAUSAL ADVANCEDBREAST-CANCER - A MULTICENTER STUDY BY THE ITMO GROUP
Authors: BUZZONI R BIGANZOLI L BAJETTA E CELIO L FORNASIERO A MARIANI L ZILEMBO N BARTOLOMEO MD LEO AD ARCANGELI G AITINI E FARINA G SCHIEPPATI G GALLUZZO D MARTINETTI A
Citation: R. Buzzoni et al., COMBINATION GOSERELIN AND TAMOXIFEN THERAPY IN PREMENOPAUSAL ADVANCEDBREAST-CANCER - A MULTICENTER STUDY BY THE ITMO GROUP, British Journal of Cancer, 71(5), 1995, pp. 1111-1114
RELIABILITY OF IMMUNORADIOMETRIC ASSAYS FOR SEX-HORMONE BINDING GLOBULIN, ANDROSTENEDIONE, 17-BETA ESTRADIOL AND TUMOR-MARKERS CEA AND CB15.3 TO ASSESS THE BIOLOGICAL RESPONSE OF MEGESTROL-ACETATE TREATMENT INPATIENTS WITH ADVANCED BREAST-CANCER
Authors: BOTTI C BOGNI A SEREGNI E VICARIO G BUZZONI R CARNAGHI C CELIO L MASSARON S BOMBARDIERI E BAJETTA E
Citation: C. Botti et al., RELIABILITY OF IMMUNORADIOMETRIC ASSAYS FOR SEX-HORMONE BINDING GLOBULIN, ANDROSTENEDIONE, 17-BETA ESTRADIOL AND TUMOR-MARKERS CEA AND CB15.3 TO ASSESS THE BIOLOGICAL RESPONSE OF MEGESTROL-ACETATE TREATMENT INPATIENTS WITH ADVANCED BREAST-CANCER, International journal of oncology, 5(4), 1994, pp. 881-888
FORMESTANE AS TREATMENT OF ADVANCED BREAST-CANCER IN ELDERLY WOMEN
Authors: ZILEMBO N BUZZONI R CELIO L NOBERASCO C FERRARI L LAFFRANCHI A VICARIO G DOLCI S BAJETTA E
Citation: N. Zilembo et al., FORMESTANE AS TREATMENT OF ADVANCED BREAST-CANCER IN ELDERLY WOMEN, Tumori, 80(6), 1994, pp. 433-437
OVARIAN-FUNCTION SUPPRESSION WITH THE GONADOTROPIN-RELEASING-HORMONE (GNRH) ANALOG GOSERELIN IN PREMENOPAUSAL ADVANCED BREAST-CANCER
Authors: BAJETTA E CELIO L ZILEMBO N BONO A GALLUZZO D ZAMPINO MG LONGHI A FERRARI L BUZZONI R
Citation: E. Bajetta et al., OVARIAN-FUNCTION SUPPRESSION WITH THE GONADOTROPIN-RELEASING-HORMONE (GNRH) ANALOG GOSERELIN IN PREMENOPAUSAL ADVANCED BREAST-CANCER, Tumori, 80(1), 1994, pp. 28-32
EFFECT OF 2 4-HYDROXYANDROSTENEDIONE DOSES ON SERUM INSULIN-LIKE GROWTH-FACTOR-I LEVELS IN ADVANCED BREAST-CANCER
Authors: FERRARI L ZILEMBO N BAJETTA E BUZZONI R NOBERASCO C MARTINETTI A CELIO L GALANTE E OREFICE S CERROTTA AM
Citation: L. Ferrari et al., EFFECT OF 2 4-HYDROXYANDROSTENEDIONE DOSES ON SERUM INSULIN-LIKE GROWTH-FACTOR-I LEVELS IN ADVANCED BREAST-CANCER, Breast cancer research and treatment, 30(2), 1994, pp. 127-132
GOSERELIN IN PREMENOPAUSAL ADVANCED BREAST-CANCER - CLINICAL AND ENDOCRINE EVALUATION OF RESPONSIVE PATIENTS
Authors: BAJETTA E ZILEMBO N BUZZONI R CELIO L ZAMPINO MG COLLEONI M ORIANA S ATTILI A SACCHINI V MARTINETTI A
Citation: E. Bajetta et al., GOSERELIN IN PREMENOPAUSAL ADVANCED BREAST-CANCER - CLINICAL AND ENDOCRINE EVALUATION OF RESPONSIVE PATIENTS, Oncology, 51(3), 1994, pp. 262-269
ENDOCRINOLOGIC AND CLINICAL-EVALUATION OF 2 DOSES OF FORMESTANE IN ADVANCED BREAST-CANCER
Authors: BAJETTA E ZILEMBO N BUZZONI R NOBERASCO C DILEO A BARTOLI C MERSON M SACCHINI V MOGLIA D CELIO L NELLI P
Citation: E. Bajetta et al., ENDOCRINOLOGIC AND CLINICAL-EVALUATION OF 2 DOSES OF FORMESTANE IN ADVANCED BREAST-CANCER, British Journal of Cancer, 70(1), 1994, pp. 145-150
PROGNOSTIC FACTORS IN PATIENTS AFFECTED BY HEPATOCELLULAR-CARCINOMA TREATED WITH SYSTEMIC CHEMOTHERAPY - THE EXPERIENCE OF THE NATIONAL-CANCER-INSTITUTE-OF-MILAN
Authors: COLLEONI M BAJETTA E NELLI P BONI L BOCHICCHIO AM NOLE F BUZZONI R CELIO L MAZZAFERRO V BONFANTI G BIGNAMI P GENNARI L
Citation: M. Colleoni et al., PROGNOSTIC FACTORS IN PATIENTS AFFECTED BY HEPATOCELLULAR-CARCINOMA TREATED WITH SYSTEMIC CHEMOTHERAPY - THE EXPERIENCE OF THE NATIONAL-CANCER-INSTITUTE-OF-MILAN, Annals of oncology, 4(6), 1993, pp. 489-493
EFFICACY AND TOLERABILITY OF 4-HYDROXYANDROSTENEDIONE (4-OHA) AS 1ST-LINE TREATMENT IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER AFTER ADJUVANT THERAPY
Authors: BAJETTA E ZILEMBO N BUZZONI R NOBERASCO C CELIO L BICHISAO E
Citation: E. Bajetta et al., EFFICACY AND TOLERABILITY OF 4-HYDROXYANDROSTENEDIONE (4-OHA) AS 1ST-LINE TREATMENT IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER AFTER ADJUVANT THERAPY, Cancer treatment reviews, 19, 1993, pp. 31-36
SALVAGE TREATMENT AFTER RINTERFERON-ALPHA-2A IN ADVANCED NEUROENDOCRINE TUMORS
Authors: ZILEMBO N BUZZONI R BAJETTA E DIBARTOLOMEO M DEBRAUD F CASTELLANI R MAFFIOLI L CELIO L VILLA E LORUSSO V FOSSER V BUZZI F
Citation: N. Zilembo et al., SALVAGE TREATMENT AFTER RINTERFERON-ALPHA-2A IN ADVANCED NEUROENDOCRINE TUMORS, Acta oncologica, 32(2), 1993, pp. 245-250
TREATMENT OF METASTATIC CARCINOIDS AND OTHER NEUROENDOCRINE TUMORS WITH RECOMBINANT INTERFERON-ALPHA-2A - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY GROUP
Authors: BAJETTA E ZILEMBO N DIBARTOLOMEO M DILEO A PILOTTI S BOCHICCHIO AM CASTELLANI R BUZZONI R CELIO L DOGLIOTTI L PINOTTI G AITINI E LABIANCA R FORNASIERO A RIVA P SCHIEPPATI G NELLI P MARIANI L ATTARD M BARDUAGNI M BELLU F BUZZI F DAPRILE M DEMARINO E EPIFANI C FARINA G FATTORI PP FERRERO B FOSSER V IIRILLO A LORUSSO V MAIFREDI G MEROZZI P PASINI F SARTI EL SCANNI A VERUSIO C VILLA E
Citation: E. Bajetta et al., TREATMENT OF METASTATIC CARCINOIDS AND OTHER NEUROENDOCRINE TUMORS WITH RECOMBINANT INTERFERON-ALPHA-2A - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY GROUP, Cancer, 72(10), 1993, pp. 3099-3105
Risultati: 1-22 |